In recent years, the rising popularity of semaglutide has become a cause for concern, with poison control centers reporting a staggering increase in calls related to this drug. The surge, amounting to over 1,500% since 2019, has predominantly been attributed to dosage errors, leading to a nightmare scenario for both patients and healthcare providers. Read more
A recent study published in Lancet Healthy Longevity suggests that bariatric surgery, a weight loss procedure, is linked to a lower risk of blood cancer, particularly in women. The research, involving over 2,000 individuals who underwent surgery and a similar group who did not, revealed a significant reduction in the incidence and mortality of blood cancers among those who had bariatric surgery. Notably, the benefit was more pronounced in women, especially those with high blood sugar levels at the beginning of the study. Read more
A recent study on the effects of stopping tirzepatide (Monjauro / Zepbound), reveals that individuals who stopped tirzepatide experienced substantial weight regain (approximately 14%), highlighting the challenges associated with relying on such medications for long-term results.
Dr. Alexander Abkin, a leading bariatric surgeon in New Jersey, emphasizes the limitations of injectable weight-loss drugs as a sustainable solution for severe obesity.
“In my professional opinion, the study reinforces the importance of lifestyle modifications and more permanent weight loss solutions”, says Dr. Abkin. He advocates for treatments that extend beyond short-term interventions like weight loss injections, emphasizing the need for comprehensive lifestyle changes, including healthier eating habits and regular physical activity, with bariatric surgery , such as sleeve gastrectomy and gastric bypass, as a more effective and enduring option for sustained weight loss.
While injectable drugs like tirzepatide may offer initial weight loss, these medications are not a magic solution for the management of severe obesity. Achieving and maintaining a healthy weight requires a fundamental shift in lifestyle.
Dr. Abkin echoes the sentiments of other physicians in the field, emphasizing that there is no “miracle drug” and that long-term success lies in lifestyle modification. He reinforces the idea that injectables can be considered as supportive elements but should not replace the fundamental changes needed for lasting weight management. This perspective aligns with the belief that bariatric surgery addresses the root causes of obesity, providing patients with a transformative and enduring solution compared to the uncertainties associated with injectable weight-loss drugs.
Advanced Laparoscopic Surgeons of Morris offers a comprehensive weight loss program for patients with severe obesity, including patient education, dietary counseling, surgical weight loss and long-term follow up care designed to keep patients on track with their weight loss goals. Contact us today to learn more.
In this 10 part series, New Jersey bariatric surgeon Dr. Alexander Abkin discusses 10 questions commonly asked by patients who are considering weight loss surgery.
Question 4 – How quickly can I expect to start losing weight? Read more
In this 10 part series, New Jersey bariatric surgeon Dr. Alexander Abkin discusses 10 questions commonly asked by patients who are considering weight loss surgery.
Question 3 – What risks are involved with bariatric surgery? Read more
In this 10 part series, New Jersey bariatric surgeon Dr. Alexander Abkin discusses 10 questions commonly asked by patients who are considering weight loss surgery.
Question 2 – What Type of Medical Tests Do I Need Before Bariatric Surgery?
In this 10 part series, New Jersey bariatric surgeon Dr. Alexander Abkin discusses 10 questions commonly asked by patients who are considering weight loss surgery.
Question 1 – Do I Qualify for Weight Loss Surgery?
A recent study was published comparing two treatments for people with obesity and a liver condition called metabolic dysfunction-associated steatotic liver disease (MASLD). The two treatments tested were bariatric surgery and a medication called semaglutide.
The findings showed that bariatric surgery led to more weight loss and better improvements in liver health compared to semaglutide. Many obese individuals also have MASLD, and losing weight is the main recommendation for treating it. Both bariatric surgery and semaglutide help people lose weight, but the study aimed to determine which one is more effective for improving liver health.
Dr. Reem Z. Sharaiha, the lead researcher, believes that using a combination of treatments may be the best approach for these patients. Semaglutide and similar medications are a good starting point, but some patients may plateau in their weight loss or want to stop taking the medication. That’s where bariatric surgery and similar procedures come in. On the other hand, patients treated with bariatric surgery may need help maintaining their weight loss, so medication could be beneficial for them.
In conclusion, the study suggests that a combination of treatments may be the future for managing obesity and MASLD, and the most important thing is to start treatment, regardless of the specific method used.
Please note, while our practice does not offer endoscopic sleeve gastroplasty (ESG), we do offer Vertical Sleeve Gastrectomy (VSG) and Roux-en-y Gastric Bypass (RNYGBP) procedures for qualified candidates who meet the criteria.
Click here to read the full study. Call 973-410-9700 or contact us online to learn more.
Joel Katz talks to Dr. Alexander Abkin about Bariatrics at Hackensack University JFK Medical Center. Click the link below to listen. Read more
Obesity has become a global health crisis, with millions of people struggling to achieve sustainable weight loss and improve their overall health. Semaglutide, a medication commonly used for type 2 diabetes management, has been praised for its potential in aiding weight loss. However, recent research has shed light on its association with gastroparesis, a condition that affects the stomach’s ability to empty properly. As we delve into the link between semaglutide and gastroparesis, it becomes evident that bariatric surgery may be a more effective and safer option for those seeking sustained weight loss with minimal complications.
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that mimics the functions of incretin hormones, leading to reduced appetite, delayed stomach emptying, and increased insulin secretion. In clinical trials, semaglutide has shown promising results in weight reduction, making it a potential game-changer in the field of obesity management.
However, the delayed gastric emptying caused by semaglutide can also lead to gastroparesis, a condition characterized by symptoms such as nausea, vomiting, bloating, and early satiety. The mechanism behind this adverse effect is not yet fully understood, and further research is needed to determine the risk factors and long-term consequences of gastroparesis related to semaglutide use.
Semaglutide has shown promise in aiding weight loss, but its link to gastroparesis raises concerns about its long-term safety and efficacy. As we navigate the complexities of obesity management, it becomes evident that bariatric surgery offers a more comprehensive and effective solution for sustained weight loss with minimal complications. Nonetheless, each individual’s case is unique, and medical professionals must carefully evaluate the risks and benefits of both approaches before recommending the most suitable course of action. Research in this field is ongoing, and future advancements may lead to safer and more effective treatments for obesity and its related complications.
Call 973-410-9700 or contact us online to learn more.
“I have been a patient of Dr. Abkin for over 3 years, since 2020. I’ve lost 85 pounds and will be forever grateful for this life changing experience. Every staff member genuinely cares in the ease and success of your journey. They leave no stone unturned. Dr. Abkin is a master at his craft and truly makes you feel comfortable with process. I’ve never felt more confident in my own skin! I will continue to refer anyone struggling with weight loss and health issues to his office. It’s a second chance at a new life!”
“Dr. Abkin’s expertise in performing my gastric sleeve surgery in 2022 was truly remarkable. From our first consultation to post-op follow-ups, he demonstrated genuine care and professionalism. The procedure went flawlessly, and I felt well-informed and confident throughout. Thanks to Dr. Abkin’s skill and guidance, I’ve achieved significant weight loss and improved health. Grateful for his exceptional care on this transformative journey.”
“After undergoing gastric sleeve surgery, I am amazed by the positive impact it has had on my life. The procedure was smooth, and the medical team was extremely supportive throughout the process. I’ve experienced significant weight loss and newfound energy. My confidence has soared, and I’m enjoying a healthier lifestyle. Grateful for this life-changing surgery.”
“Today, at the age of 45, I can confidently say that I am in the best shape of my life. I feel great, and my depression is a thing of the past. I have found purpose once again. And now, I am eager to share my story with all of you. Dr. Abkin and Dr. Jawed, you have saved my life! You have given my wife her husband back, and my children have their father again!”
“Enormously thankful to Dr. Abkin for changing my life! Lost over 150 lbs after having sleeve surgery in 2019. His expertise and support made my transformation possible. Forever grateful!”
“Dr. Abkin was so friendly and explained each procedure thoroughly. I never felt forced or not heard, which really made me feel very comfortable with going forward with the surgery. Well a year later and I’m reflux free and still losing weight and extremely happy with all my services from him and his staff! I have referred him several times to my friends and co workers and will keep referring him!”
Please enter your information below: By submitting this form, I agree to be contacted via phone, text, email. Reply ‘STOP’ to opt-out of marketing at any time.